Real-Time Release Testing
Real-time release testing (RTRT) is the ability, formally defined in EU GMP Annex 17, to evaluate and ensure the quality of in-process and finished product based on process data — typically a validated combination of measured material attributes and process controls — rather than relying solely on a battery of finished-product laboratory tests performed after manufacturing is complete.
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 19 LINKSReal-time release replaces a finished-product test with an argument, and the argument is only as strong as the weakest input: a site that cannot defend its process model has moved risk earlier, not removed it.
06 · QUALITY MATURITY — REAL-TIME RELEASE TESTING, REACTIVE TO ADAPTIVE
Release rests entirely on finished-product laboratory results. In-process data informs operators and nothing else.
A real-time release approach is proposed and approved in the filing, but the surrogate measurements have not been shown to predict the attribute they stand in for.
Each surrogate is demonstrated to predict its attribute across the range that matters, the approved approach matches what the line runs, and a fallback to laboratory testing is defined.
Predictive performance is monitored in service, so degradation of the relationship surfaces before a release decision rests on a relationship that no longer holds.
Release is a continuous property of the process rather than an event at the end of it, and the laboratory test exists to confirm the model rather than to make the decision.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 4
Derived from the 4 standards SPEQ maps to this subject, across 2 regulatory bodies: ICH, EMA.
RECORDS & OBJECTIVE EVIDENCE
- The approved real-time release approach as filed, and the attributes it covers
- Evidence that each in-process measurement predicts the finished-product attribute it replaces
- The defined fallback to laboratory testing, and records of occasions it was invoked
- Ongoing verification data comparing predicted results against confirmatory testing
- The batch disposition record showing which decision rested on which measurement
COMMON INSPECTION FINDINGS
- Surrogate measurements accepted as equivalent without data establishing the predictive relationship
- The approach as operated diverging from the approach as approved in the filing
- No defined fallback, so a measurement failure leaves the batch without a disposition route
- Predictive performance never re-verified after a formulation, equipment or supplier change
- Release decisions recorded without identifying which measurement supported which attribute
RTRT Versus Parametric Release
Parametric release is the older, narrower concept: for terminally sterilized products, a validated sterilization cycle plus confirmed process parameters can substitute for finished-product sterility testing, because the physics of the sterilization cycle itself is considered more reliable evidence than a probabilistic sterility test on a small sample. RTRT is the broader, Quality-by-Design-enabled concept: it can apply to any critical quality attribute — potency, uniformity, dissolution — not only sterility, wherever sufficient process understanding and measurement exist to justify it.
What Has to Be in Place Before RTRT Is Credible
RTRT is not simply a testing shortcut — Annex 17 and the underlying ICH Q8/Q10 framework expect a validated process understanding, a documented control strategy tying in-process measurements to the finished-product attribute they are substituting for, and process analytical technology capable of generating that data reliably in real time. Attempting RTRT without this foundation inverts the logic: it becomes testing less without actually knowing more.
Regulatory Basis
RTRT is most explicitly codified in EU GMP Annex 17, which sets out the assessment and validation expectations a manufacturer must satisfy before regulatory acceptance of an RTRT strategy for a given product and attribute.
The Mindset Shift RTRT Represents
SPEQ interpretation: RTRT deliberately moves away from a “test quality in” mindset, where a batch’s fate is decided by a sample tested after the fact, toward a “quality is demonstrated as it is built” mindset, where the process itself generates the evidence of conformance continuously. This is philosophically consistent with — and difficult to achieve without — the continuous manufacturing approaches described in ICH Q13.
FREQUENTLY ASKED
Is parametric release the same thing as real-time release testing?
Parametric release is a specific, older application of the same underlying logic, historically focused on substituting a validated sterilization cycle for finished-product sterility testing. RTRT is the broader concept, applicable to a wider range of quality attributes.
Does RTRT eliminate finished-product testing entirely?
Not necessarily — an RTRT strategy can replace some or all of a given finished-product test, depending on what has been validated; it is defined and justified attribute by attribute, not as an all-or-nothing switch for the whole product.
What regulatory document defines real-time release testing?
EU GMP Annex 17, “Real Time Release Testing and Parametric Release,” is the primary regulatory reference setting out its scope and validation expectations.
Why is process analytical technology a prerequisite for RTRT?
RTRT depends on generating reliable, timely data about the attribute being substituted for; without in-line or on-line measurement capability, there is no data source to build the substitution on.